Alcon stock falls 4% after lens implant sales slip and guidance narrows
FROM THE WIRE · FINANCE.YAHOO.COM
This article first appeared on GuruFocus. Alcon (NYSE:ALC) shares fell 4% at 11.14 a.m. ET on Wednesday, November 11, in regular trading, after the Swiss eye-care group reported a 2% drop in implantables sales on U.S. competitive pressure and narrowed its 2026 outlook.…
Read at the source ↗MARKET IMPACTNEUTRAL✦ News Impact agent estimateTone: expected bearishWeaker implantables sales and a narrower outlook weigh on the shares of this large eye-care group.AI-generated summary
✦ IN BRIEF · AIAI-generated summary
- 01Third-quarter net sales rose 5% to $2.7 billion, with Surgical up 4% and Vision Care up 6%.
- 02Implantables fell 2% to $422 million on U.S. competitive pressure.
- 03Core diluted EPS rose 15% to $0.91, while constant-currency core EPS growth guidance narrowed to 12-14%.
- 04Shares fell 4% in regular trading on Wednesday, November 11.
NEWS IMPACT AND MARKET REACTIONChange from the reference price
Alcon Inc.72.46 USDMarket closedtoday -2.16%Negative Alcon Inc.59.48 CHFMarket closedtoday -3.88%Negative
Impact and summary are estimates by the News Impact AI agent, not financial advice.Open in Markets